UnitedHealth Group Inc (NYSE:UNH) stock is dragging the Dow and its sector today, after the health insurer suspended its 2025 guidance amid steeper-than-anticipated expenditure issues.
UnitedHealth Group Incorporated faces a dramatic stock drop following a rare earnings miss, where Q1 revenues fell short by $2 billion and EPS missing by $0.09. CEO Andrew Witty's sudden resignation and the company's withdrawal of all guidance due to higher-than-expected costs have further shaken investor confidence. The company is grappling with increased insurance usage and costs, particularly in Medicare Advantage, impacting its ability to provide accurate future earnings guidance.
The already turbulent situation for UnitedHealth (NYSE: UNH) has only worsened with a deluge of adverse developments. The latest turmoil on Tuesday, May 13 ensured that UNH stock collapsed 10.17% in pre-market from its latest closing price of $378.75 to $340.25 at the time of publication.
Former CEO and current chairman Stephen Hemsley is stepping back into the top job following the abrupt resignation of Andrew Witty, UnitedHealth said.
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) shares fell over 10% in premarket trading after the health insurance giant withdrew its guidance for the current year and announced the departure of its chief executive officer. Stephen J.
Chairman Stephen Hemsley will return to running the healthcare giant he helped build, succeeding CEO Andrew Witty.
Stephen J. Hemsley will take over as chief executive replacing current CEO Andrew Witty.
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UnitedHealth shares fell 22% on April 17, wiping out about $119 billion of market value, after the insurer cut its 2025 forecast.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
UnitedHealth Group is reportedly increasing its use of artificial intelligence across its business. The company has 1,000 AI applications in production, The Wall Street Journal reported Monday (May 5).
But artificial intelligence on its own will never deny a claim, assures the insurer's chief digital and technology officer